News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

In Their Shoes: 65 Years of IAFF’s Fight for MDA

By Lindsey Baker | March 5, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | March 5, 2019
Blog Post

CMTA and MDA Co-Fund Proof-of-Concept Study Using AAV Vector to Deliver Gene Replacement Therapy in X-linked Charcot-Marie-Tooth Disease

By Jeanene Swanson | March 1, 2019
Blog Post

FDA Accepts Sarepta Therapeutics’ New Drug Application (NDA) for Golodirsen to Treat DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | March 1, 2019
Blog Post

MDA Releases New DMD Fact Sheet During Duchenne Muscular Dystrophy Awareness Week

By MDA Staff | February 13, 2019
Blog Post

Long-Term Results of Extension Study Validate Surgery as a Treatment for Myasthenia Gravis

By Jeanene Swanson | February 12, 2019
MDA logo
Blog Post

Trexo Robotics Releases Trexo Home Walking Aid for Children

By MDA Staff | February 11, 2019
Blog Post

Solid Biosciences Announces Preliminary Results of DMD Gene Therapy Trial

By Jeanene Swanson | February 8, 2019
Blog Post

Arkansas to Screen Babies for SMA

By MDA Staff | February 7, 2019
MDA logo
Blog Post

Catalyst Pharmaceuticals Announces Positive Results from Phase 2b Trial of Firdapse in Patients with Muscle-Specific Kinase Antibody Positive Myasthenia Gravis (MuSK-MG)

By Jeanene Swanson | January 30, 2019